|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP
|
|
|
|
When a vendor of important reagents like antibody supplier Abcam charges big money, those high Abcam prices could negatively impact research in the long run. Some of the prices are so high that buying just a few antibodies could take up a small but meaningful slice of an entire R01 grant. Sky-high Abcam prices I've noticed that Abcam prices for …
|
|
|
|
|
|
|
|
Perspectives on new stem cells for paralysis paper & media coverage
|
|
|
|
A new paper on stem cells for paralysis from a Mayo Clinic team has sparked a bit of legitimate hope but also some hype in the media. The publication was in Nature Communications. It is entitled "Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial." The approach was direct injection of mesenchymal stromal/stem cells or …
|
|
|
|
|
|
